These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 26517216)

  • 21. Addenbrooke's cognitive examination III: diagnostic utility for detecting mild cognitive impairment and dementia in Parkinson's disease.
    Sousa NMF; Brucki SMD
    Arq Neuropsiquiatr; 2023 Feb; 81(2):155-163. PubMed ID: 36863401
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cut-off score of the Mattis Dementia Rating Scale for screening dementia in Parkinson's disease.
    Llebaria G; Pagonabarraga J; Kulisevsky J; García-Sánchez C; Pascual-Sedano B; Gironell A; Martínez-Corral M
    Mov Disord; 2008 Aug; 23(11):1546-50. PubMed ID: 18546326
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cognitive screening in substance users: Diagnostic accuracies of the Mini-Mental State Examination, Addenbrooke's Cognitive Examination-Revised, and Montreal Cognitive Assessment.
    Ridley N; Batchelor J; Draper B; Demirkol A; Lintzeris N; Withall A
    J Clin Exp Neuropsychol; 2018 Mar; 40(2):107-122. PubMed ID: 28436744
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The interlocking finger test in patients with Parkinson's disease and healthy subjects.
    Souza CP; Oliveira GN; Foss MP; Tumas V
    J Clin Neurosci; 2016 Jul; 29():145-8. PubMed ID: 26960261
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Performance of three cognitive screening tools in a sample of older New Zealanders.
    Cheung G; Clugston A; Croucher M; Malone D; Mau E; Sims A; Gee S
    Int Psychogeriatr; 2015 Jun; 27(6):981-9. PubMed ID: 25603424
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Spectroscopic changes associated with mild cognitive impairment and dementia in Parkinson's disease.
    Pagonabarraga J; Gómez-Ansón B; Rotger R; Llebaria G; García-Sánchez C; Pascual-Sedano B; Gironell A; Delfino M; Ruscalleda J; Kulisevsky J
    Dement Geriatr Cogn Disord; 2012; 34(5-6):312-8. PubMed ID: 23208306
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cognitive complaints in Parkinson's disease patients: from subjective cognitive complaints to dementia and affective disorders.
    Barbosa RP; Mendonça MD; Caetano AP; Lampreia TM; Miguel R; Bugalho PM
    J Neural Transm (Vienna); 2019 Oct; 126(10):1329-1335. PubMed ID: 31278557
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Screening for Cognitive Impairment in Parkinson's Disease: Improving the Diagnostic Utility of the MoCA through Subtest Weighting.
    Fengler S; Kessler J; Timmermann L; Zapf A; Elben S; Wojtecki L; Tucha O; Kalbe E
    PLoS One; 2016; 11(7):e0159318. PubMed ID: 27437705
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Validation of the Turkish Version of the Montreal Cognitive Assessment Scale (MoCA-TR) in patients with Parkinson's disease.
    Ozdilek B; Kenangil G
    Clin Neuropsychol; 2014; 28(2):333-43. PubMed ID: 24528299
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Psychometric properties and diagnostic usefulness of the Addenbrooke's Cognitive Examination-Revised in a Chilean elderly sample].
    Muñoz-Neira C; Henríquez Ch F; Ihnen J J; Sánchez C M; Flores M P; Slachevsky Ch A
    Rev Med Chil; 2012 Aug; 140(8):1006-13. PubMed ID: 23282773
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Validation of the Cuban Version of Addenbrooke's Cognitive Examination-Revised for Screening Mild Cognitive Impairment.
    Broche-Pérez Y; López-Pujol HA
    Dement Geriatr Cogn Disord; 2017; 44(5-6):320-327. PubMed ID: 29393151
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Test Your Memory-Spanish version (TYM-S): a validation study of a self-administered cognitive screening test.
    Muñoz-Neira C; Henríquez Chaparro F; Delgado C; Brown J; Slachevsky A
    Int J Geriatr Psychiatry; 2014 Jul; 29(7):730-40. PubMed ID: 24390843
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A meta-analysis of the accuracy of the Addenbrooke's Cognitive Examination (ACE) and the Addenbrooke's Cognitive Examination-Revised (ACE-R) in the detection of dementia.
    Larner AJ; Mitchell AJ
    Int Psychogeriatr; 2014 Apr; 26(4):555-63. PubMed ID: 24423470
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of screening tools for the assessment of mild cognitive impairment: preliminary findings.
    Ahmed S; de Jager C; Wilcock G
    Neurocase; 2012; 18(4):336-51. PubMed ID: 22044211
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Validation of the Korean Addenbrooke's Cognitive Examination for diagnosing Alzheimer's dementia and mild cognitive impairment in the Korean elderly.
    Heo JH; Lee KM; Park TH; Ahn JY; Kim MK
    Appl Neuropsychol Adult; 2012; 19(2):127-31. PubMed ID: 23373580
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Global cognitive performance is associated with sleep efficiency measured by polysomnography in patients with Parkinson's disease.
    Sobreira EST; Sobreira-Neto MA; Pena-Pereira MA; Chagas MHN; Fernandes RMF; Eckeli AL; Tumas V
    Psychiatry Clin Neurosci; 2019 May; 73(5):248-253. PubMed ID: 30636105
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Utility and limitations of Addenbrooke's Cognitive Examination-Revised for detecting mild cognitive impairment in Parkinson's disease.
    Komadina NC; Terpening Z; Huang Y; Halliday GM; Naismith SL; Lewis SJ
    Dement Geriatr Cogn Disord; 2011; 31(5):349-57. PubMed ID: 21613789
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Validation of a novel Montreal Cognitive Assessment scoring algorithm in non-demented Parkinson's disease patients.
    Sulzer P; Becker S; Maetzler W; Kalbe E; van Nueten L; Timmers M; Machetanz G; Streffer J; Salvadore G; Scholz E; Tkaczynska Z; Brockmann K; Berg D; Liepelt-Scarfone I
    J Neurol; 2018 Sep; 265(9):1976-1984. PubMed ID: 29936665
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Validation of the Sinhala Version of the Addenbrooke's Cognitive Examination-Revised for the Detection of Dementia in Sri Lanka: Comparison with the Mini-Mental Status Examination and the Montreal Cognitive Assessment.
    Suriyakumara V; Srikanth S; Wijeyekoon R; Gunasekara H; Muthukuda C; Rajapaksha D; Weerasekara R; Gonawala L; Wijekoon N; de Silva KRD
    Dement Geriatr Cogn Disord; 2019; 47(4-6):198-208. PubMed ID: 31311022
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Utility of the Mattis dementia rating scale to assess the efficacy of rivastigmine in dementia associated with Parkinson's disease.
    Dujardin K; Devos D; Duhem S; Destée A; Marié RM; Durif F; Lacomblez L; Touchon J; Pollak P; Péré JJ
    J Neurol; 2006 Sep; 253(9):1154-9. PubMed ID: 16998649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.